celastrol has been researched along with Heart Disease, Ischemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aceros, H; Borie, M; Der Sarkissian, S; Mansour, S; Noiseux, N; Stevens, LM | 1 |
| Borie, M; Cailhier, JF; Der Sarkissian, S; Gaboury, L; Hamet, P; Mansour, S; Noiseux, N; Stevens, LM | 1 |
2 other study(ies) available for celastrol and Heart Disease, Ischemic
| Article | Year |
|---|---|
Celastrol-type HSP90 modulators allow for potent cardioprotective effects.
Topics: Animals; Cardiotonic Agents; Cell Line; Heart; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Pentacyclic Triterpenes; Rats; Rats, Inbred Lew; Signal Transduction; Triterpenes | 2019 |
Celastrol protects ischaemic myocardium through a heat shock response with up-regulation of haeme oxygenase-1.
Topics: Animals; Cardiotonic Agents; Cell Line; Cell Survival; DNA-Binding Proteins; Female; Heat Shock Transcription Factors; Heat-Shock Response; Heme Oxygenase (Decyclizing); HSP70 Heat-Shock Proteins; Hypoxia; MAP Kinase Signaling System; Myocardial Ischemia; Myocardium; Oncogene Protein v-akt; Pentacyclic Triterpenes; Phosphatidylinositol 3-Kinases; Rats, Sprague-Dawley; Reactive Oxygen Species; Transcription Factors; Triterpenes; Up-Regulation | 2014 |